Koji Inoue

4.0k total citations
183 papers, 2.7k citations indexed

About

Koji Inoue is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, Koji Inoue has authored 183 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 72 papers in Pulmonary and Respiratory Medicine, 57 papers in Surgery and 51 papers in Oncology. Recurrent topics in Koji Inoue's work include Lung Cancer Treatments and Mutations (31 papers), Lung Cancer Research Studies (22 papers) and Cancer Immunotherapy and Biomarkers (13 papers). Koji Inoue is often cited by papers focused on Lung Cancer Treatments and Mutations (31 papers), Lung Cancer Research Studies (22 papers) and Cancer Immunotherapy and Biomarkers (13 papers). Koji Inoue collaborates with scholars based in Japan, France and United States. Koji Inoue's co-authors include S Hukuda, Toshio Ushiyama, Junichi Nishioka, Yoshio Takei, Maho Ogoshi, Hideo Bannai, Tetsushi Kawahara, Satoru Miyano, H. Ueyama and Yoichi Nakanishi and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer.

In The Last Decade

Koji Inoue

174 papers receiving 2.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Koji Inoue Japan 29 677 677 638 636 345 183 2.7k
Rani Kanthan Canada 30 468 0.7× 571 0.8× 501 0.8× 852 1.3× 113 0.3× 128 2.9k
Kōichi Nagao Japan 31 540 0.8× 851 1.3× 472 0.7× 1.2k 1.9× 253 0.7× 196 3.2k
Lawrence M. Silverman United States 28 1.2k 1.7× 586 0.9× 917 1.4× 894 1.4× 209 0.6× 97 3.6k
Diane Felsen United States 34 637 0.9× 376 0.6× 928 1.5× 516 0.8× 193 0.6× 112 3.2k
Pascale Marcorelles France 29 311 0.5× 498 0.7× 762 1.2× 328 0.5× 191 0.6× 138 2.6k
Andreas Schmiedl Germany 29 726 1.1× 374 0.6× 595 0.9× 616 1.0× 75 0.2× 116 2.4k
Satoshi Takeuchi Japan 26 378 0.6× 457 0.7× 550 0.9× 616 1.0× 93 0.3× 184 2.7k
Hiroki Ito Japan 28 1.1k 1.6× 367 0.5× 442 0.7× 517 0.8× 327 0.9× 190 2.9k
Jessica Williams United Kingdom 28 477 0.7× 495 0.7× 479 0.8× 723 1.1× 159 0.5× 103 2.5k
Giulia Ottaviani Italy 30 936 1.4× 452 0.7× 1.1k 1.7× 616 1.0× 299 0.9× 123 3.9k

Countries citing papers authored by Koji Inoue

Since Specialization
Citations

This map shows the geographic impact of Koji Inoue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Koji Inoue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Koji Inoue more than expected).

Fields of papers citing papers by Koji Inoue

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Koji Inoue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Koji Inoue. The network helps show where Koji Inoue may publish in the future.

Co-authorship network of co-authors of Koji Inoue

This figure shows the co-authorship network connecting the top 25 collaborators of Koji Inoue. A scholar is included among the top collaborators of Koji Inoue based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Koji Inoue. Koji Inoue is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hotta, Katsuyuki, Sho Saeki, Shinya Sakata, et al.. (2025). Five-year outcomes with gefitinib induction and chemoradiotherapy in EGFR-mutant stage III non-small-cell lung cancer: LOGIK0902/OLCSG0905 phase II study. International Journal of Clinical Oncology. 30(3). 497–503.
2.
Inoue, Koji, et al.. (2024). Distal preservation and retrograde resection of the anterior vaginal wall in female robot‐assisted radical cystectomy. Asian Journal of Endoscopic Surgery. 18(1). e13399–e13399.
3.
4.
Abe, Yohei, Masashi Kubota, Yoichiro Tohi, et al.. (2024). Efficacy and safety of dose‐dense gemcitabine plus cisplatin as neoadjuvant chemotherapy for muscle‐invasive bladder cancer. International Journal of Urology. 31(10). 1102–1106. 1 indexed citations
5.
Morita, Ayako, Eiki Ichihara, Koji Inoue, et al.. (2024). Impacts of probiotics on the efficacies of immune checkpoint inhibitors with or without chemotherapy for patients with advanced non‐small‐cell lung cancer. International Journal of Cancer. 154(9). 1607–1615. 14 indexed citations
6.
Kato, Takuma, Hiromi Hirama, Toshiyuki Kamoto, et al.. (2024). Long-term outcomes of the first prospective study of active surveillance for prostate cancer in Japan. International Journal of Clinical Oncology. 29(10). 1557–1563. 1 indexed citations
7.
Kubo, Toshio, Eiki Ichihara, Daijiro Harada, et al.. (2023). Efficacy of immune checkpoint inhibitor monotherapy in elderly patients with non-small-cell lung cancer. Respiratory Investigation. 61(5). 643–650. 3 indexed citations
8.
Tanimura, Keiko, Junji Uchino, Hideharu Kimura, et al.. (2023). Ramucirumab Plus Docetaxel for Patients with Non-small cell Lung Cancer with Brain Metastases: A Multicenter, Open-Label Single-Arm Phase II Trial. The Oncologist. 28(6). 551–e454. 6 indexed citations
9.
Hosokawa, Shinobu, Eiki Ichihara, Daijiro Harada, et al.. (2022). Pembrolizumab in advanced NSCLC patients with poor performance status and high PD-L1 expression: OLCSG 1801. International Journal of Clinical Oncology. 27(7). 1139–1144. 4 indexed citations
10.
Kubota, Masashi, Takashi Matsuoka, Issei Suzuki, et al.. (2022). Effect of continued perioperative antithrombotic therapy on bleeding outcomes following laparoscopic nephrectomy and nephroureterectomy. Asian Journal of Endoscopic Surgery. 16(1). 7–13. 1 indexed citations
11.
Ichihara, Eiki, Daijiro Harada, Koji Inoue, et al.. (2020). Characteristics of patients with EGFR-mutant non-small-cell lung cancer who benefited from immune checkpoint inhibitors. Cancer Immunology Immunotherapy. 70(1). 101–106. 28 indexed citations
12.
Ichihara, Eiki, Daijiro Harada, Koji Inoue, et al.. (2019). The impact of body mass index on the efficacy of anti-PD-1/PD-L1 antibodies in patients with non-small cell lung cancer. Lung Cancer. 139. 140–145. 74 indexed citations
13.
Kawano, Yuko, T. Sasaki, Hiroyuki Yamaguchi, et al.. (2018). Phase I/II study of carboplatin plus nab-paclitaxel and concurrent radiotherapy for patients with locally advanced non–small cell lung cancer. Lung Cancer. 125. 136–141. 16 indexed citations
14.
Takei, Yoshio, Hirofumi Hashimoto, Koji Inoue, et al.. (2008). Central and peripheral cardiovascular actions of adrenomedullin 5, a novel member of the calcitonin gene-related peptide family, in mammals. Journal of Endocrinology. 197(2). 391–400. 19 indexed citations
15.
Itaba, Soichi, Tsutomu Iwasa, Tadashi Misawa, et al.. (2007). Pneumocystis Pneumonia During Combined Therapy of Infliximab, Corticosteroid, and Azathioprine in a Patient with Crohn’s Disease. Digestive Diseases and Sciences. 52(6). 1438–1441. 16 indexed citations
16.
Nagatomo, Izumi, Toru Kumagai, Tadahiro Yamadori, et al.. (2006). The Gefitinib-Sensitizing Mutant Epidermal Growth Factor Receptor Enables Transformation of a Mouse Fibroblast Cell Line. DNA and Cell Biology. 25(4). 246–251. 10 indexed citations
17.
Inoue, Koji. (2005). Structural and Functional Evolution of Three Cardiac Natriuretic Peptides. Molecular Biology and Evolution. 22(12). 2428–2434. 45 indexed citations
18.
Inoue, Koji, et al.. (1996). Asymptomatic big toe changes in diabetic patients with early Charcot knees–a report of 2 cases. Acta Orthopaedica Scandinavica. 67(3). 302–304. 3 indexed citations
19.
Inoue, Koji, et al.. (1995). Increased rate of hysterectomy in women undergoing surgery for osteoarthritis of the knee. Osteoarthritis and Cartilage. 3(3). 205–209. 10 indexed citations
20.
Harada, Teruhiko, et al.. (1984). Endolymphatic Hydrops and III Type Allergic Reaction. 15(1). 189–192. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rani Kanthan Breakdown of academic impact, for papers by Kōichi Nagao Breakdown of academic impact, for papers by Lawrence M. Silverman Breakdown of academic impact, for papers by Diane Felsen Breakdown of academic impact, for papers by Pascale Marcorelles Breakdown of academic impact, for papers by Andreas Schmiedl Breakdown of academic impact, for papers by Satoshi Takeuchi Breakdown of academic impact, for papers by Hiroki Ito Breakdown of academic impact, for papers by Jessica Williams Breakdown of academic impact, for papers by Giulia Ottaviani
Rankless by CCL
2026